Morning Movers: Precigen surges following full FDA approval of Papzimeos

S&P 500 index futures are up 0.1% as U.S. retail sales rose in July, but less than expected.

On the global stage, markets traded near record highs as investors looked ahead to the high-stakes summit between President Trump and Russia’s President, Vladimir Putin, in Alaska. Expectations of progress on Ukraine and a potential thaw in global tensions are underpinning cautious optimism across equity markets.

In pre-market trading, S&P 500 futures are up 0.11%, Nasdaq futures are down 0.09% and Dow futures are up 0.58%

Check out this morning’s top movers from around Wall Street, compiled by The Fly, and subscribe to the Fly By on YouTube.

HIGHER –

• Precigen (PGEN) up 49% after announcing that the FDA has granted full approval to Papzimeos for the treatment of adults with recurrent respiratory papillomatosis
• United Health (UNH), Lennar (LEN) and D.R. Horton (DHI) up 10%, 3% and 3%, respectively, after the disclosure of Warren Buffett’s Berkshire Hathaway holding stakes in the companies
• Intel (INTC) up 3% in a follow-through to yesterday’s strength after Bloomberg reported that the Trump administration is in talks to have the U.S. government potentially take a stake in the chipmaker to support efforts to expand domestic manufacturing

UP AFTER EARNINGS –

• BitFuFu (FUFU) up 12%

DOWN AFTER EARNINGS –

• Applied Materials (AMAT) down 12%
• SanDisk (SNDK) down 6%
• Flowers Foods (FLO) down 2%